SIM
BSX.PRA
SSI Investment Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-92,185
| Closed | -$11.1M | – | 264 |
|
|
2023
Q1 | $11.1M | Sell |
92,185
-335
| -0.4% | -$40.4K | 0.78% | 33 |
|
|
2022
Q4 | $10.6M | Buy |
92,520
+16,740
| +22% | +$1.92M | 0.67% | 38 |
|
|
2022
Q3 | $7.76M | Sell |
75,780
-27,225
| -26% | -$2.79M | 0.52% | 61 |
|
|
2022
Q2 | $10.5M | Sell |
103,005
-380
| -0.4% | -$38.6K | 0.66% | 46 |
|
|
2022
Q1 | $12M | Buy |
103,385
+595
| +0.6% | +$69.2K | 0.66% | 44 |
|
|
2021
Q4 | $11.7M | Buy |
+102,790
| New | +$11.7M | 0.69% | 40 |
|